STOM
Stomatin
Also known as: BND7, EPB7, EPB72, STOM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P27105
- Gene
- STOM
- Ensembl
- ENSG00000148175
- Chromosome
- 9
- Canonical length
- 288 aa
- Protein class
- Plasma proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles,Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of a highly conserved family of integral membrane proteins. The encoded protein localizes to the cell membrane of red blood cells and other cell types, where it may regulate ion channels and transporters. Loss of localization of the encoded protein is associated with hereditary stomatocytosis, a form of hemolytic anemia. There is a pseudogene for this gene on chromosome 6. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]
Canonical amino-acid sequenceUniProt
288 residues, UniProt reviewed canonical sequence.
>P27105|STOM
1 MAEKRHTRDS EAQRLPDSFK DSPSKGLGPC GWILVAFSFL FTVITFPISI WMCIKIIKEY
61 ERAIIFRLGR ILQGGAKGPG LFFILPCTDS FIKVDMRTIS FDIPPQEILT KDSVTISVDG
121 VVYYRVQNAT LAVANITNAD SATRLLAQTT LRNVLGTKNL SQILSDREEI AHNMQSTLDD
181 ATDAWGIKVE RVEIKDVKLP VQLQRAMAAE AEASREARAK VIAAEGEMNA SRALKEASMV
241 ITESPAALQL RYLQTLTTIA AEKNSTIVFP LPIDMLQGII GAKHSHLGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STOM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 338 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 338 nTPM
- liver: 332 nTPM
- adipose tissue: 318 nTPM
- placenta: 256 nTPM
- lung: 233 nTPM
- breast: 201 nTPM
Single-cell type
- platelets: 1,321 nCPM
- neutrophil progenitors: 1,253 nCPM
- vascular endothelial cells: 573 nCPM
- kupffer cells: 540 nCPM
- smooth muscle cells: 482 nCPM
- alveolar cells type 1: 459 nCPM
Immune cell
- gdT-cell: 169 nTPM
- MAIT T-cell: 166 nTPM
- memory CD8 T-cell: 153 nTPM
- NK-cell: 148 nTPM
- total PBMC: 129 nTPM
- memory CD4 T-cell: 85 nTPM
Brain region
- medulla oblongata: 159 nTPM
- midbrain: 146 nTPM
- hypothalamus: 143 nTPM
- thalamus: 139 nTPM
- basal ganglia: 129 nTPM
- pons: 128 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.67
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- host-mediated activation of viral genome replication
- positive regulation of protein targeting to membrane
- positive regulation of viral process
- regulation of monoatomic ion transmembrane transport
Molecular functions
- identical protein binding
- ion channel inhibitor activity
- protein homodimerization activity
- RNA polymerase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STOM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STOM as an antibody target. Whether an autoantibody or antibody against STOM could matter depends on whether native STOM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STOM is annotated at the cell surface, where native STOM is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label STOM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...